about
Classification of Therapeutic and Experimental Drugs for Brown Adipose Tissue Activation: Potential Treatment Strategies for Diabetes and ObesityLiraglutide suppresses obesity and induces brown fat-like phenotype via Soluble Guanylyl Cyclase mediated pathway in vivo and in vitro.Pharmacologic activation of estrogen receptor β increases mitochondrial function, energy expenditure, and brown adipose tissue.Metabolically Active Three-Dimensional Brown Adipose Tissue Engineered from White Adipose-Derived Stem Cells.Blaming the Brain for Obesity: Integration of Hedonic and Homeostatic Mechanisms.
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Bioengineering Beige Adipose Tissue Therapeutics
@ast
Bioengineering Beige Adipose Tissue Therapeutics
@en
Bioengineering Beige Adipose Tissue Therapeutics
@nl
type
label
Bioengineering Beige Adipose Tissue Therapeutics
@ast
Bioengineering Beige Adipose Tissue Therapeutics
@en
Bioengineering Beige Adipose Tissue Therapeutics
@nl
prefLabel
Bioengineering Beige Adipose Tissue Therapeutics
@ast
Bioengineering Beige Adipose Tissue Therapeutics
@en
Bioengineering Beige Adipose Tissue Therapeutics
@nl
P2860
P356
P1476
Bioengineering Beige Adipose Tissue Therapeutics
@en
P2093
Andreas Stahl
P2860
P356
10.3389/FENDO.2015.00164
P407
P50
P577
2015-01-01T00:00:00Z